Ameritas Investment Partners, Inc. Arcellx, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,367 shares of ACLX stock, worth $383,553. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,367
Previous 4,223
3.41%
Holding current value
$383,553
Previous $233,000
56.22%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ACLX
# of Institutions
205Shares Held
44.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$351 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$342 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$329 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$309 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$216 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.85B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...